We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > diagnostic tests

News List

RCGP calls for better access to cancer diagnostic tests pharmatimes
November 29, 2018
GP access to appropriate diagnostic tests in the community is currently amongst the lowest in Europe, a report by The Health Foundation has found.
TP taps Almac to develop repotrectinib pan-cancer companion diagnostic fiercebiotech
November 02, 2018
TP Therapeutics and Almac Diagnostic Services have launched a global collaboration to develop a pan-cancer companion diagnostic test for TP’s repotrectinib, aimed at...
Exact Sciences ups its forecast after 241,000 Cologuard screenings in Q3 fiercebiotech
November 02, 2018
Exact Sciences announced third-quarter revenues of $118.3 million after it screened about 241,000 people with its Cologuard at-home test for colorectal cancer—a 49% increase
Blood tester Guardant Health files for Nasdaq IPO fiercebiotech
September 10, 2018
Guardant also plans to submit its test for international regulatory approvals, to help boost its coverage and reimbursements.
Amarantus reacquires three diagnostic tests biospectrumasia
April 10, 2018
Under the terms of the deal, Amarantus will cancel about $722,000 in liabilities, owed by Avant. Amarantus will issue to Avant 1 million shares of its common stock, and Avant will issue to Amarantus an additional 32 million shares of its common stock as a